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KESAN MIKRORNA MENSASARKAN IL17RA UNTUK MENGAWAL 
EKSPRESI RANKL DAN OPG DALAM SEL STEM DARIPADA GIGI SUSU 
MANUSIA YANG TERLUPAS  
ABSTRAK 
 
Kini, IL17A telah menjadi kunci utama dalam pembentukan semula tulang. 
Pengaturan osteoprotegerin (OPG) dan pengaktifan reseptor factor nuclear kapa-β 
ligan (RANKL) oleh IL17A telah dijelaskan dalam sel stem mesenchymal manusia 
(hMSC). Di sini, matlamat kajian ini adalah untuk menentukan potensi mikroRNA 
yang menyasarkan IL17RA dan kesannya terhadap ekspresi OPG dan RANKL dalam 
sel stem daripada gigi susu manusia yang terlupas (SHED). MikroRNA yang 
berpotensi telah diramal dengan menggunakan tiga program algoritma yang terkini 
iaitu DIANA-micro T CDS, TargetScan v7.1 dan miRWalk v2.0 melalui proses 
penapisan yang kompleks secara in silico. Kepekatan mikroRNA yang mensasarkan 
GAPDH telah dioptimumkan untuk mendapatkan penurunan ekspresi GAPDH yang 
paling berkesan. Kepekatan 25, 50 dan 100 nM dengan tempoh pemindahan selama 
48 jam diuji dengan mikroRNA-kawalan negatif sebagai kawalan negatif. Keputusan 
menunjukkan tahap mRNA GAPDH adalah terendah pada kepekatan 50 nM selepas 
dinilai oleh PCR masa nyata kuantitatif dan dinormalisasi dengan β-actin. Kepekatan 
ini boleh digunakan sebagai kepekatan miRNA umum dalam kajian ini. SHED telah 
dikulturkan dalam media penting minimum alfa (αMEM) yang lengkap dengan media 
osteogenik (OM) dan dirawat dengan 50 ng/mL interleukin 17A (rIL17A) rekombinan 
selama 7 hari (fasa osteogenik awal). Sel yang dirawat kemudiannya ditransmisikan 
dengan 50 nM mimik kawalan positif, kawalan negatif dan mikroRNA yang diramal 
xvi 
 
dari kajian silico iaitu hsa-miR-6761-5p dan hsa-miR-4524a-3p. Pengurangan nilai 
gen sasaran dan kesannya terhadap penanda osteogenik dinilai dengan mengukur 
ekspresi IL17RA, OPG, RANKL dan GAPDH oleh PCR masa nyata kuantitatif serta 
dinormalisasi dengan β-actin. Oleh itu, kedua-dua mimik mikroRNA menunjukkan 
penurunan gen IL17RA dan hsa-miR4524a-3p telah menunjukkan penurunan yang 
lebih kuat (p < 0.001) apabila dibandingkan dengan hsa-miR-6761-5p (p < 0.01). Di 
samping itu, terdapat pengurangan ketara kepada ekspresi OPG dari kedua-dua 
mikroRNA dan penurunan RANKL juga diperhatikan dalam kedua-dua SHED yang 
ditrasfeksikan, namun pengurangan itu tidak ketara. Penemuan ini menunjukkan 
peranan mikroRNA yang menyasarkan IL17RA dalam ungkapan OPG dan RANKL 













THE EFFECT OF MICRORNA TARGETING IL17RA IN REGULATING 
THE EXPRESSION OF RANKL AND OPG IN STEM CELLS FROM 
HUMAN EXFOLIATED DECIDUOUS TEETH 
ABSTRACT 
 
IL17A is now becoming a key role in bone remodelling. The regulations of 
osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-β ligand 
(RANKL) by IL17A were briefly explained in human mesenchymal stem cell (hMSC). 
Herein, the aim of the present study was to determine the potential microRNA 
targeting IL17RA and its effects toward OPG and RANKL expression in stem cell from 
human deciduous teeth (SHED). Potential microRNA was predicted by using three 
latest algorithmically programs such as DIANA-micro T CDS, TargetScan v7.1 and 
miRWalk v2.0 through a complex filtration process via in silico. The concentration of 
microRNA-targeting GAPDH was optimised for the most efficient downregulation of 
GAPDH mRNA. The concentrations of 25, 50 and 100 nM and transfection duration 
of 48 hours were tested with microRNA-mimic negative control (microRNA-mimic 
NC) as a negative control. The results showed the GAPDH mRNA level was lowest at 
concentration of 50 nM after evaluated by quantitative real time PCR and normalised 
with β-actin. This concentration can be used as the general miRNA concentration in 
this study. SHED was cultured in complete alpha minimum essential media (αMEM) 
supplemented with osteogenic media (OM) and treated with 50 ng/mL of recombinant 
interleukin 17A (rIL17A) for 7 days (early osteogenic phase). Treated cells were then 
transfected with 50 nM of positive control mimic, negative control mimic and 
predicted microRNAs mimic from in silico study which are hsa-miR-6761-5p and hsa-
miR-4524a-3p. Downregulation of target gene and its effects towards osteogenic 
xviii 
 
markers were evaluated by measuring the expressions of IL17RA, OPG, RANKL and 
GAPDH by quantitative real-time PCR and normalised with β-actin. Hence, 
transfections of both microRNA mimics showed downregulation of IL17RA gene 
which hsa-miR4524a-3p showed stronger downregulation (p < 0.001) when compared 
to hsa-miR-6761-5p (p <0.01). In addition, there was a significant downregulation of 
OPG expression from both microRNAs and downregulation of RANKL was also noted 
in both transfected SHED, however the reduction was not significant. These findings 
demonstrate the role of microRNA targeting IL17RA in the expression of OPG and 






1.1 Background of the study 
 
Vital functions of bone are protection, movement, leverage, mineral storage as well 
as a source of hematopoietic cells and stem cells. Bone formation and resorption are 
constantly being remodelled in bone metabolism process (Nam and Kampa, 2013). 
Stiff, light and flexible are important characteristics of the bone to make loading and 
facilitate movement. Role players in bone remodelling cycle are osteoblast which 
mediated the bone formation and bone resorption by osteoclasts (Stavre et al., 2016).  
 
The activity of the cycle must be dynamically balance to maintain the integrity of the 
constituent cell types in bone. Osteoblast produced the organic bone matrix which 
mediated mineralisation whereas the osteocytes dissolves bone mineral and 
enzymatically degrades extracellular matrix (ECM) proteins through its unique type 
of exocrine cell (Crockett et al., 2011). 
 
The past decade has seen the immune and skeletal systems are played a complex role 
by sharing several regulatory molecules such as receptors, cytokines and 
transcription factors (Rucci, 2008). Wide range of signalling pathways regulated the 
complex sequence of events in the skeletal development process (Gámez, Rodriguez-




The signalling molecules include osteoprotegerin (OPG), receptor activator of 
nuclear factor-β ligand (RANKL) and receptor activator of nuclear factor-β (RANK) 
are played important roles in the regulation of bone (Boyce and Xing, 2007). 
Formation of multinucleated osteoclasts, their activation and survival in normal and 
pathologic conditions of bone remodelling are regulated by RANKL/RANK 
signalling. Binding of OPG with RANKL would protect the skeleton from excessive 
bone resorption and preventing RANKL to bind with its receptor. These are 
important to determine bone mass and skeletal integrity (Jones, Kong and Penninger, 
2002). 
 
Recent developments in the field of bone repair have led to a renewed interest in 
stem cell research. Self-renewal capacity, osteogenic lineage differentiation and 
trophic factors secretions are the main characteristics of mesenchymal stem cells 
(MSCs) that may contribute to cellular therapies in bone repair (Fanganiello et al., 
2015).  
 
In recent years, there has been an increasing interest in stem cell from human 
exfoliated deciduous teeth (SHED) which showed the expressions of mesenchymal 
stem cell markers such as STRO-1 and CD146 but negative for haematopoietic 
markers such as CD45, CD11b/c and HLADR. In addition, SHED has been reported 
to undergo osteogenic differentiation and generated bone in vivo which led to high 






Previous studies have attempted to explain the role of IL17A in osteogenesis which 
showed increased in ALP activity and decreased RANKL mRNA expression (Osta et 
al. 2014). Conversely, Lin et al. (2014) has reported IL17A could significantly 
increase the expression of RANKL and downregulated the expression of OPG in 
human periodontal ligament cells.  
 
IL17A which commonly known as IL17 was one of the six members in the IL17 
cytokine family including IL17B, IL17C, IL17D IL17E and IL17F. The biological 
function and regulation of IL17A and IL17F were best understood (Jin and Dong, 
2013). On the other hand, significant events were induced in many tissues after the 
binding of IL17 to its receptor (Raychaudhuri, Raychaudhuri and Genovese, 2012).  
 
The first IL17 binding protein to be identified was IL17RA. IL17RA is ubiquitously 
expressed at the mRNA level, although surface expression varies widely. Because 
the IL-17R superfamily shares only minimal homology with other receptors (Maitra 
et al., 2007). 
 
The past decade has seen the rapid development of microRNAs (miRNAs) research 
in osteogenic differentiation where these would provide a unique regulatory layer 
that is essential for the regulation of gene expression in most metazoans (Brennecke 




RNA-induces silencing complex (RISC) guided by these small RNAs which the size 
about 22 nucleotides in length to 3’ UTR of selected mRNAs target site (Hofacker, 
2007). These would provide a new dimension to the post-transcriptional control of 
cells which were considered the key epigenetic mechanisms in bone remodelling by 
inhibiting mRNA translation.  
 
Therefore, numerous miRNAs have been found to be involved in the regulation of 
bone homeostasis, and they play critical roles in bone remodelling (Jing et al., 2015). 
Collectively, we outline a critical role of microRNA-targeting IL17RA in regulating 





















1.2 Statement of the problem 
Six ligands including IL17A to IL17F are exclusively the IL17 cytokine family 
which signal through five receptors namely IL17RA to IL17RE. A number of 
researchers have reported the roles of IL17RA in bone-destructive mechanism (Loss 
et al., 2010), rheumatoid arthritis (Kehlen et al., 2002), glioma stem cell (Parajuli et 
al., 2015) and recent evidence suggest the major role of inhibition of IL17A and 
IL17RA in pathological condition (Beringer, Noack and Miossec, 2016). 
 
In addition, IL17A promoting effects on the osteogenic differentiation of isolated 
human bone marrow-derived mesenchymal stem cells (hMSCs) was reported by Osta 
et al. 2014. In addition, IL17A promoted osteoblastogenesis in bone regeneration 
process (Ono et al., 2016). IL17 stimulation in hMSC are important in osteogenic 
differentiation which suggests the interaction between IL17 and IL17RA in 
osteogenesis (Kim et al., 2014).  
 
What is not yet clear is the effect of microRNA targeting IL17RA towards the 
osteogenic differentiation in SHED where the overall mechanism of RANKL/OPG in 
osteogenic differentiation of SHED has not been studied so far. The physiological 







1.3 Justification of study 
We examined the potential molecular mechanisms regulating the expression of 
IL17RA.  In depth analysis of the regulatory role of these important cytokine and its 
receptor could provide further understanding on the underlying mechanism in bone 
remodelling. Some miRNAs play critical roles in immunoregulation and these results 
provide an insight into the roles of IL17RA in mediating physiological role of bone. 
In contrast, these microRNA targeting IL17RA may play important role in other 




















1.4 Research objectives 
1.4.1 General Objective 
a.) To determine the effect of microRNA targeting IL17RA in regulating 
RANKL and OPG expression in SHED. 
 
1.4.2 Specific Objective 
a.) To predict and identify the interaction between microRNAs and human 
IL17RA mRNAs and to elucidate the sequence-dependent regulation of 
IL17RA by miRNAs by in silico study. 
 
b.) To verify the effect of the predicted microRNAs targeting IL17RA on the 
levels of IL17RA mRNA transcript by quantitative real-time PCR. 
 
c.) To investigate the effect of microRNA targeting IL17RA on osteogenic 
markers expression, OPG and RANKL by quantitative real-time PCR. 
 
 
1.5 Research Hypothesis 
MicroRNA targeting IL17RA regulates osteogenic markers expression, OPG and 










2.1 Bone and teeth 
There is a large volume of published studies describing the role of bone and teeth in 
research and its important in orthopaedic and orthodontic field. In response to 
hormones, growth factors and mechanical loading, bone is continuously formed and 
absorbed (Nam and Kampa, 2013). The rigidity, hardness as well as power of 
regeneration and repair were the important characteristics of bone as specialized 
supporting framework of the body (Fogelman, Van Der Wall and Gnanasegaran, 
2012). 
 
Modelling (reshaping) of bone is important to help it adapts with biomechanical 
forces and influences remodelling of bone to enable it to eliminate old or micro-
damaged bone and replace it with new bone. These processes are crucial to enhance 
mechanical strength of bone (Raisz, 1999). 
 
Cortical bone and trabecular bone were two components of bone which cortical bone 
is dense, solid and surrounds the marrow space whereas the trabecular bone consist 
of honeycomb-like network of trabecular plates and rods interspersed in the bone 




Generally, bone protects the vital organs, producing marrow-derived cell for both 
blood forming and fat storage, acts as a mineral reservoir for calcium homeostasis 
and a storage of growth factors and cytokines, and also takes part in acid–base 
balance (Birmingham et al., 2012). 
 
In contrast, development of teeth is crucial at the correct positions in relation to the 
forming jaw bones. Tooth-associated bone namely alveolar bone enables teeth to 
attach to the jaw bones via periodontal ligament (Lin et al., 2014). Sequential and 
reciprocal interactions between the oral ectoderm and neural crest-derived 














2.2 Bone remodelling 
Bone is a dynamic tissue, subjected to a continuous renewing during the life of each 
individual by the process of bone remodelling (Fogelman et al. 2012) Balanced 
homeostasis between bone formation and resorption are crucial in maintaining 
dynamic bone structure and function, eliminate ischemic or micro-fractured bone and 
to ensure a correct calcium homeostasis (Raisz, 1999). In early foetal life, 
remodelling of bone begins and involves a series of process of both cell lineages 
mediated by mesenchymal osteoblastic lineage and the hematopoietic osteoclastic 
lineage (Crockett et al., 2011). 
 
From Figure 2.1, interaction of osteoclast and osteoblast precursor cells were the 
initial “activation” stage and led to migration, differentiation and fusion of large 
multinucleated osteoclasts which initiates resorption to the mineralized bone surface 
(Rucci, 2008). These cells degrade all the bone matrix components by secretion of 
hydrogen ions and lysozyme enzymes especially cathepsin K (Teitelbaum, 2000). 
Whereas, osteoblast cells contribute to deposit the organic components of bone 
extracellular matrix and control the resorption activity of osteoclasts by monitoring 
recruitment, differentiation and maturation of osteoclast (Caetano-Lopes, Canhao 
and Fonseca, 2000). 
 
Meanwhile, Multinucleated cells osteoclasts were formed by the fusion of 
mononuclear progenitors of the monocyte or macrophage family and played a central 
role in resorptive of bone (Fogelman, Van Der Wall and Gnanasegaran, 2012). 
Several factors were expressed by the osteoclast associated with bone resorption that 
11 
 
regulate osteoblast function. Osteocytes and bone lining cells were two components 
of bone that important in mechanosensor function, osteoblast and osteoclast activity 
modulation and mineral homeostasis regulation (Teitelbaum, 2000). Both osteoblast 
and osteoclast have an equal important role in the regulation of bone mass. 
 
Large Golgi apparatus and abundant rough endoplasmic reticulum were visible when 
mononuclear osteoblasts were activated. In addition, tight junction formation with 
adjacent osteoblasts facilitate the regions of plasma membrane in vesicular 
trafficking and secretion (Caetano-lopes and Canhão, 2007). The differentiation led 
to secretion of bone matrix and giving rise to osteocytes resulted from trapped 
osteoblasts in bone matrix. Through the plasma membrane of osteocytes, they 
communicate with each other and their surrounding which act as mechanosensor to 














Figure 2.1 The schematic drawing shows the origin and fate of osteoblasts and 













2.3 RANKL/RANK/OPG in bone remodelling  
In 1990, the RANKL/RANK/OPG system was discovered for the regulation of bone 
which accelerated the fundamental understanding of bone remodelling and modelling 
regulation (Boyce and Xing, 2007). For many years, we have known that osteoblastic 
stromal cells regulated osteoclast formation and discovered the 
RANKL/RANK/OPG system would have extensive functions beyond regulation of 
bone remodelling (Boyce and Xing, 2008). 
 
Formation, activation and survival of osteoclast was regulated by RANKL/RANK 
signalling in normal remodelling and pathological conditions (Jones, Kong and 
Penninger, 2002). As showed in Figure 2.2, protection of bone from excessive 
resorption was mediated by OPG by binding to RANKL which would prevent the 
ligand to bind with its receptor, RANK (Oshita et al., 2011). The relative 
concentration of RANKL and OPG in bone is important to determine the mass and 
strength of bone (Baharuddin et al., 2015).  
 
RANK, RANKL and OPG showed dynamic spatiotemporal expression patterns 
during odontogenesis and osteogenesis (Ohazama, Courtney and Sharpe, 2004). A 
critical regulator of osteoblast differentiation in the presumptive dentary bone region, 
runt-related gene 2 (Cbfa1/Runx2) showed similar expression as RANKL from E12 
and discussed the role of RANKL in early ossification centre for dentary bone 
formation. Moreover, these expression pattern showed that RANK and OPG are 




At early stages of development, connections between the formation of ossification 
centre for dentary bone and tooth was developed from the well-established 
interactions among RANK, RANKL and OPG (Heinrich et al., 2005). These 













Figure 2.2 The schematic drawing showed the RANKL/RANK/OPG system signal 












2.4 Mesenchymal stem cell (MSCs) 
Mesenchymal stem cell or stromal stem cells are multipotent stem cells (MSC) 
mainly reside in bone marrow (BM) and also been isolated from other tissues. MSC 
are capable to differentiate in vitro and in vivo through many pathways such as bone, 
cartilage, cardiac cells, skeletal muscle, neural cells, tendon, adipose and connective 
tissue (Ayatollahi et al., 2012).  
 
In 1976, MSCs was first described as the clonal and plastic-adherent cells and these 
multipotent cells have giving many advantages characteristics such as multilineage 
potential, immunosuppressive ability and ease to gene modification which would 
give promising future for tissue engineering, gene therapy applications and 
immunotherapy (Sotiropoulou et al., 2006).  
 
MSCs have three minimum criteria include 1) MSCs show fibroblast-like 
morphology and plastic adherent properties under normal culture conditions; 2) 
MSCs express some markers such as CD24, CD90, CD105, Sca-1, SSEA-4, CD11b, 
and Sdc4 on their surface while lack expression of others surface markers such as 
CD133, CD14, CD19, CD34, CD45 and HLA-DR and 3) MSCs have great self-






Besides their potential in cardiogenic and neurogenic differentiation, they would 
differentiate into three lineages such as osteoblasts, adipocytes and chondrocytes 
under appropriate conditions (Sotiropoulou et al., 2006). Therefore, remarkable 
attention has been arose to use the potential of MSCs in many discipline of science 



















2.5 Stem cell from human exfoliated deciduous teeth 
Adult stem cell was widely used in research and clinical treatments due to their 
ability in multilineage differentiation potential while maintaining their unique 
characteristics. In contrast, adult stem cells were less controversial compared with 
embryonic stem cells which involving tissue engineering (Lee et al., 2015).  
 
Despite this, dental tissue has becoming a promising source of MSCs and they are 
easily accessible. There are few of stem cells that can be isolated from orofacial 
region include stem cells isolated from human exfoliated deciduous teeth (SHED), 
dental pulp stem cells (DPSC), dental follicle stem cells (DFSC) and periodontal 
ligament stem cells (PDLSC) as presented in Figure 2.3 (Yildirim et al., 2016).  
 
On the other hand, in spite of knowledge about the types of dental tissues, SHED has 
giving a new promising benefits in regenerative medicine due to their multipotent 
stemness (Gazarian and Ramírez-García, 2017). SHED has capability to develop into 
odontoblasts, adipocytes, neural cells and osteo-inductive cells (Wang et al., 2012).  
 
Recent evidence suggested that SHED displayed high expression of the MSC 
markers such as CD73, CD90, CD44, the osteoblast markers Runx2, CBFA1 and 
collagen I, the cartilage cell markers Col10a1, the adipose cell markers PPARγ2 and 
the neuronal stem cell markers, Nestin. In contrast, SHED showed low expression of 
the hematopoietic stem cell marker CD34 (Zhang et al., 2016). Additionally, SHED 
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shows negative expression for CD18, CD31, CD34, CD49d, CD49e, CD106, CD133, 
CD184, CD197, CD146, and HLA II cell surface markers (Yildirim et al., 2016).  
 
Advantages of SHED were explained in previous studies where it exhibits a higher 
proliferative rate than other types of dental stem cells and shown excellent 
bone/dentin formation capacity in single colony-derived SHED clones in immune-
deficient mice (Zhang et al., 2016). In addition, SHED has been used to reconstruct 
trabecular bone in systemic lupus erythematosus-like in mice and helped in critical-
size calvarial defect regeneration in Wistar rats (Fanganiello et al., 2015).  
 
SHED also may be a suitable resources for regeneration of alveolar and orofacial 
bone defects due to their similar tissue origin with mandibular bone (Bartosh et al., 
2013). Recent study showed the beneficial role of SHED in neurodegenerative 
disease treatment due to their neurotrophic factors secretion and could be utilized in 
alleviating Parkinson’s disease, Alzheimer’s disease and cerebral palsy 





Figure 2.3 Adapted from (Bartosh et al., 2013). The picture shows the sources of human dental tissue-derived MSCs. Abbreviations: 
ABMSCs, alveolar bone derived mesenchymal stem cells; DFPCs, dental follicle progenitor cells; DPSCs, dental pulp stem cells; GMSCs, 
gingiva-derived MSCs; PDLSCs, periodontal ligament stem cells; SCAP, stem cells from the apical papilla; SHED, stem cells from exfoliated 




2.6 IL-17 Cytokines and Receptors 
In 1993, IL17 which originally called CTLA8 was cloned and its functional role 
remained uncertain to a decade until it came into breakthrough with the discovery of 
a new population of CD4+ T helper (Th) cells that involved in expression of IL17 in 
2005 (Liu et al., 2013). 
 
The discovery of this subset became known as type 17 T helper (Th17) cells and has 
been devoted to comprehending the development, differentiation and regulation of 
this lineage mechanism (Amatya, Garg and Gaffen, 2017). Characteristic of IL17 
gene was studied with subsequent studies include pro-inflammatory cytokines, 
chemokines, antimicrobial peptides (AMPs), matrix metalloproteinases (MMPs) and 
inflammatory effectors (Beringer, Noack and Miossec, 2016). 
 
IL17A, IL17B, IL17C, IL17D, IL17E and IL17F were six structurally related 
cytokines in IL17 family which they are co-expressed on linked genes and co-
produced by Th17. Whereas, IL17R family consists of five receptors subunits 
namely IL17RA, IL17RB, IL17RC, IL17RD and IL17RE. Both IL17A and IL17F 
exist either as homodimer or as a heterodimer that induce signals through dimeric 






Generally, non-haematopoietic cells are the main responders to IL17 even though the 
IL17R is expressed ubiquitously. IL17 was shown to activate NF-kB and induce NF-
kβ-dependent cytokines which first demonstrated the pro-inflammatory role of IL17 
in fibroblast (Huang et al., 2009). IL17 also has a role in haematopoiesis and 
differentiation of hMSC as well as neutrophil recruitment (Sivanathan et al., 2015). 
Intracellular signal transduction pathways including protein kinase A, JAK/STAT, 
and mitogen-activated protein kinases MAPKs were triggered when IL17RA 
activated (Krstic et al., 2015).  
 
Act1 and TNF receptor-associated factor (TRAF) were recruited after binding of 
IL17A with its receptor and activates MAPK (Lin et al., 2014). In IL17A deficient 
mice, bone regeneration was impaired due to decrease in osteoblastic bone formation 
(Huang et al., 2006).  
 
Previous study showed IL17A promoted osteoblastic bone formation (Ono et al., 
2016). In human bone marrow derived mesenchymal stem cells, leptin production 
was significantly increased which inhibited adipogenesis and promoted osteogenesis 
via JAK/STAT signalling (Mojsilović et al., 2015). In addition, IL17A increased 
ALP activity during osteogenesis (Osta et al., 2014). Colony frequency and size of 
individual colonies of hMSC was significantly increased by IL17A in vitro in a dose-





In contrary, other studies have found that the osteoclastogenesis was induced by Th17 
cells through secreting IL17, RANKL, TNF, IL6 and low expression of IFNγ (Ono et 
al., 2016) and released of RANKL by osteoblast and osteocytes after stimulation of 
IL17 cytokine which favour osteoclastogenic activity of RANKL by enhancing 
RANK in bone loss inflammatory conditions (Pacifici, 2016). Meanwhile, 
pathological conditions such as arthritis or periodontal disease may be due to IL17-
dependent RANKL expression in osteoblast which lead to differentiation and 
















2.7 MicroRNA biogenesis 
In most eukaryotes, the endogenous non-coding 21-23 nucleotide long RNA 
sequences microRNA or miR or miRNA are found and shown a post-transcriptional 
ability in gene expression regulation (Hofacker, 2007). In Figure 2.4 (a), RNA 
polymerase II will transcribe miR genes and two complementary proteins namely 
Drosha and Pasha will process the primary transcript called pri-miRNA (Friedman et 
al., 2009). 
 
These proteins will shape and shorten the pri-miRNA into approximately 70 
nucleotide hairpin (stem-loop) by removing 5’ cap and poly-A tail called pre-
miRNA. This process is important in forming pre-miRNA and development of 
mature miRNA. Next, transport protein Exportin 5 associated with a Ran-GTP will 
facilitate the pre-miRNA to export out of the nucleus through the nucleus pores 
(Wahid et al., 2010). 
 
Based on the Figure 2.4 (b), endonuclease Dicer will process the pre-miRNA in 
cytoplasm which further shortens the pre-miRNA into a 20 - 25 nucleotide double-
stranded miRNA molecule with 2 nucleotide overhang on each 3’ end (Mohr and 
Mott, 2015). The loop was removed by Dicer through cleavage so that both ends of 
the miRNA duplex are exposed. These initiates the formation of RNA-induced 
silencing complex (RISC) for association of the mature miRNA. One strand of the 
double stranded miRNA will be integrated into the RISC and the most stable 5’ end 
strand will be selected by the Argonaute protein (Rupaimoole and Slack, 2017). 
 
